Drug combo cuts fracture risk for women with osteoporosis – Futurity – Futurity: Research News

Futurity: Research NewsDrug combo cuts fracture risk for women with osteoporosis – FuturityFuturity: Research NewsFor post-menopausal women with severe osteoporosis, the combination of two medications could build and maintain bone mass.Analysis examines link between bone turnover markers and fracture …EurekAlert (press release)all 3 news articles Source:: Osteoporosis Feed       

Analysis examines link between bone turnover markers and fracture risk in osteoporosis trials – EurekAlert (press release)

Analysis examines link between bone turnover markers and fracture risk in osteoporosis trialsEurekAlert (press release)Pooled data from 14 osteoporosis clinical trials of anti-resorptive drugs indicate that patients who have reduced levels of two bone turnover markers during treatment have lower risks of later experiencing vertebral fractures. No bone turnover markers … Source:: Osteoporosis Feed       

‘Bone Glue’ Experiments on the ISS Test Possible Treatment for Osteoporosis – Seeker

Seeker’Bone Glue’ Experiments on the ISS Test Possible Treatment for OsteoporosisSeekerHess said space is the perfect environment to study key findings in how Tetranite works with patients who have osteoporosis, since it provides conditions that aren’t available on Earth. The experiment focuses on how osteoblasts grow in microgravity in …and more Source:: Osteoporosis Feed       

Clinical trial of novel approach to treating osteoporosis represents “significant breakthrough,” according to … – McGill Newsroom

www.ottawacommunitynews.com/Clinical trial of novel approach to treating osteoporosis represents “significant breakthrough,” according to …McGill NewsroomA regimen of a novel bone anabolic medication (which builds bone mass) followed by an antiresorptive agent (which maintains bone mass) has been shown to significantly reduce the risk of fracture among post-menopausal women with severe osteoporosis …Top 5 bone, mineral … Continue reading

National Osteoporosis Foundation Elects Elizabeth A. Thompson as its New CEO – PR Newswire (press release)

National Osteoporosis Foundation Elects Elizabeth A. Thompson as its New CEOPR Newswire (press release)The organization has an outstanding record for developing innovative, high-quality programming for patients and physicians involved in the diagnosis and treatment of patients with and at risk for osteoporosis and fractures,” Thompson said. “With its …and more Source:: Osteoporosis Feed       

Lower Risk of New Fractures With Teriparatide Compared With Risedronate in Osteoporosis – Rheumatology Advisor

Rheumatology AdvisorLower Risk of New Fractures With Teriparatide Compared With Risedronate in OsteoporosisRheumatology AdvisorTeriparatide is associated with a lower risk for new vertebral and clinical fractures compared with risedronate in post-menopausal women being treated for severe osteoporosis, according to a multicenter double-blind study published in The Lancet. Source:: Osteoporosis Feed       

USPSTF: Screen All Women 65 and Older for Osteoporosis – AAFP News

AAFP NewsUSPSTF: Screen All Women 65 and Older for OsteoporosisAAFP NewsBased on its review of the evidence, the USPSTF recommended screening for osteoporosis with bone measurement testing to prevent osteoporotic fractures in women 65 and older — a “B” recommendation. (www.uspreventiveservicestaskforce.org). The task … Source:: Osteoporosis Feed       

Osteoporosis Warrants Long-term Treatment – Medscape

Osteoporosis Warrants Long-term TreatmentMedscape”Bisphosphonates are by far the most common drugs used to treat osteoporosis,” but the mechanism of their action is different than that of other osteoporosis therapies, Dr McClung told Medscape Medical News. “The whole idea of a drug holiday from … Source:: Osteoporosis Feed       

New IOF Compendium documents osteoporosis, its management and global burden – Medical Xpress

Medical XpressNew IOF Compendium documents osteoporosis, its management and global burdenMedical XpressThe projected increase in osteoporosis and fragility fractures documented in the Compendium is dramatic and is expected to pose a huge and growing challenge on healthcare systems. In 2010 the number of individuals aged 50 years and over at high risk of …The International … Continue reading

VIDEO: Anabolic agents should be prescribed early for high-risk osteoporosis – Healio

VIDEO: Anabolic agents should be prescribed early for high-risk osteoporosisHealioPHILADELPHIA — In this video exclusive, Neil C. Binkley, MD, professor in the divisions of geriatrics and endocrinology, associate director of the Institute on Aging and co-director or the Osteoporosis Clinical Center and Research Program at the … Source:: Osteoporosis Feed       

Intensive resistance training safe, effective for women with osteoporosis – Reuters

Intensive resistance training safe, effective for women with osteoporosisReutersAll the participants had bone mineral density testing with a special type of X-ray called a DXA scan before and after the eight-month training program to assess changes in their bone mineral density (BMD), or bone health, at the spine and the femoral …and more Source:: DXA … Continue reading

A bone-resorption surface-targeting nanoparticle to deliver anti-miR214 for osteoporosis therapy – Dove Medical Press

A bone-resorption surface-targeting nanoparticle to deliver anti-miR214 for osteoporosis therapyDove Medical PressAbstract: With increasing fracture risks due to fragility, osteoporosis is a global health problem threatening postmenopausal women. In these patients, osteoclasts play leading roles in bone loss and fracture. How to inhibit osteoclast activity is the … Source:: Osteoporosis Feed       

Calcium in the prevention of postmenopausal osteoporosis: EMAS Clinical Guide – WebWire (press release)

WebWire (press release)Calcium in the prevention of postmenopausal osteoporosis: EMAS Clinical GuideWebWire (press release)Osteoporosis is common and affects 1 in 3 women. Calcium is vital for strong healthy bones and worldwide scientific societies have issued guidance about the daily requirements from childhood to old age. The European Menopause and Andropause Society …and more Source:: Osteoporosis … Continue reading

Romosozumab Plus Alendronate Reduces Fracture Risk in Postmenopausal Osteoporosis – Endocrinology Advisor

Romosozumab Plus Alendronate Reduces Fracture Risk in Postmenopausal OsteoporosisEndocrinology AdvisorHealthDay News — Romosozumab treatment followed by alendronate is linked to reduced risk of fractures vs alendronate alone for postmenopausal women with osteoporosis, according to a study published online in the New England Journal of Medicine. Source:: Osteoporosis Feed       

Abaloparatide Fracture Reductions Sustained in Osteoporosis – Medscape

MedscapeAbaloparatide Fracture Reductions Sustained in OsteoporosisMedscapeDENVER — Substantial reductions in fracture risk in postmenopausal women with osteoporosis seen after 18 months of treatment with the new osteoanabolic drug abaloparatide (Tymlos, Radius Health) are sustained for up to 2 years after switching to … Source:: Osteoporosis Feed       

Denosumab prevents trabecular microstructure deterioration in postmenopausal osteoporosis – Healio

Denosumab prevents trabecular microstructure deterioration in postmenopausal osteoporosisHealioPostmenopausal women with low bone mineral density assigned denosumab therapy had less deterioration of trabecular microstructure at the distal tibia compared with women assigned placebo, study findings show. “Trabecular bone strength is determined … Source:: Osteoporosis Feed       

Desonumab Discontinuation for Osteoporosis: What Are the Risks? – Rheumatology Advisor (registration)

Rheumatology Advisor (registration)Desonumab Discontinuation for Osteoporosis: What Are the Risks?Rheumatology Advisor (registration)Discontinuing desonumab therapy in osteoporosis may increase the risk of vertebral fractures, according to a systematic literature review recently published in Bone.1 In addition, measures and treatments aimed at curbing treatment-associated bone loss … Source:: Osteoporosis Feed       

Florianopolis, Brazil – Osteoporosis Essentials for Clinicians

The core elements of this program provide a set of standard practices and information to raise the level of awareness and education in bone densitometry and osteoporosis. The Osteoporosis: Essentials Course covers the latest techniques and knowledge on densitometry and the physiology, epidemiology, diagnosis and management of osteoporosis.

Kuala Lumpur, Malaysia – Osteoporosis Essentials

The core elements of this program provide a set of standard practices and information to raise the level of awareness and education in bone densitometry and osteoporosis. The Osteoporosis: Essentials Course covers the latest techniques and knowledge on densitometry and the physiology, epidemiology, diagnosis and management of osteoporosis.

Brussels, Belgium – Osteoporosis Essentials

The core elements of this program provide a set of standard practices and information to raise the level of awareness and education in bone densitometry and osteoporosis. The Osteoporosis: Essentials Course covers the latest techniques and knowledge on densitometry and the physiology, epidemiology, diagnosis and management of osteoporosis.

Yerevan, Armenia – Osteoporosis Essentials

The core elements of this program provide a set of standard practices and information to raise the level of awareness and education in bone densitometry and osteoporosis. The Osteoporosis: Essentials Course covers the latest techniques and knowledge on densitometry and the physiology, epidemiology, diagnosis and management of osteoporosis.